Jove
Visualize
Contact Us

Related Experiment Videos

PET in lung cancer.

Hans C Steinert1

  • 1Department of Medical Radiology, Nuclear Medicine, University Hospital of Zurich, Switzerland.

Chang Gung Medical Journal
|August 10, 2005
PubMed
Summary

Positron emission tomography-computed tomography (PET-CT) accurately stages lung cancer, improving treatment decisions. This imaging technique is vital for detecting metastases and assessing treatment response, enhancing patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

18F-Choline-PET in parathyroid carcinoma.

Oral oncology·2018
Same author

Early Timing of Thyroidectomy for Hyperthyroidism in Graves' Disease Improves Biochemical Recovery.

World journal of surgery·2017
Same author

[CME: Radioactive iodine therapy in thyroid cancer].

Praxis·2015
Same author

[Radioactivity: curse and blessing].

Praxis·2012
Same author

Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2012
Same author

PET and PET-CT of lung cancer.

Methods in molecular biology (Clifton, N.J.)·2011
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Accurate lung cancer staging is crucial for effective treatment planning.
  • Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) shows high accuracy in differentiating benign from malignant lung nodules.
  • Integrated PET-CT enhances the precise correlation of functional imaging findings with anatomical structures.

Purpose of the Study:

  • To evaluate the role of PET-CT in lung cancer staging.
  • To assess the diagnostic accuracy of PET-CT for T staging and mediastinal nodal staging.
  • To determine the impact of PET-CT on therapeutic management and detection of recurrent disease.

Main Methods:

  • Utilized integrated PET-CT for anatomical and functional imaging of lung cancer.
  • Assessed T staging, mediastinal nodal staging, and detection of extrathoracic metastases.
  • Evaluated the accuracy of FDG-PET in distinguishing recurrent disease from treatment effects.

Main Results:

  • PET-CT demonstrated superior diagnostic accuracy for T staging and differentiating tumor from atelectasis.
  • PET-CT proved effective for mediastinal nodal staging, identifying additional disease in 6% of patients.
  • PET detected unexpected metastases in 10-20% of patients, altering management in ~20% and accurately identifying recurrent disease.

Conclusions:

  • PET-CT is a highly accurate and valuable tool for comprehensive lung cancer staging.
  • It significantly impacts therapeutic management by detecting unexpected disease and assessing treatment response.
  • PET-CT is becoming the standard imaging modality for lung cancer staging, with ongoing research into new radiotracers.

Related Experiment Videos